My HPRA: Register

AMIKIN

100 mg/2ml Solution for Injection

Bristol-Myers Squibb (Holdings) LimitedPA0048/004/004

Main Information

Trade NameAMIKIN
Active SubstancesAMIKACIN SULFATE
Strength100 mg/2ml
Dosage FormSolution for Injection
Licence HolderBristol-Myers Squibb (Holdings) Limited
Licence NumberPA0048/004/004

Group Information

ATC CodeJ01GB06 Other aminoglycosides

Status

Authorised/WithdrawnAuthorised
Licence Issued15/07/1976
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.